Blossoming In Vitro Diagnostics Market in India Surpasses $250 Million in 2006!

New York, December 26, 2006 — As the population in India continues to prosper and migrate towards metropolitan settings where healthcare is available, a new market research study from Kalorama Information paints a picture of the high growth in vitro diagnostics (IVD) industry which has been averaging between 15% and 20% in annual growth rates.

According to Clinical Diagnostics in India, 2006 revenues will top $250 million by year’s end. Due to favorable market factors, including new private insurance programs, a continuously expanding number of laboratories, and a healthy economy, the market is expected to continue to maintain its double-digit growth rates over the next three years.

Not surprisingly, the lion’s share of the market comes from the routine chemistry segment which makes up 42% of the revenues. Immunochemistry diagnostics follow closely behind with a 32% market share. Availability of new tests and increased screening resulting from a greater understanding of lifestyle-related diseases are helping to increase revenues and drive new trends in this evolving market.

“Two interesting trends have already emerged which should be key to continued market growth,” notes Steven Heffner, the publisher of Kalorama Information. “Large manufacturers are asserting more control over their distribution with several important international manufacturers setting up shop in India, and the appearance of Chinese products in the market is just beginning and will provide increased availability of diagnostic tests.”

Authored by well-known Seattle-based research team McEvoy & Farmer, the report provides essential historical perspectives from their 10+ years of on-the-ground primary research in the Asian IVD marketplace. Their comprehensive analysis examines India’s market for IVD tests in the following market sectors: routine chemistry, critical care chemistry, hematology, urinalysis, coagulation, immunochemistry, and molecular testing.

Clinical Diagnostics in India provides an in-depth look at critical market data including current size of reagents and instrumentation by subsegment; number of units and tests by type including average costs per test; profiles and market share of major suppliers; a detailed directory of in-country suppliers and distributors; and more. It is available from Kalorama Information by clicking http://www.kaloramainformation.com/Clinical-Diagnostics-India-1362420. It is also available at MarketResearch.com.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit www.KaloramaInformation.com.